Altimmune ALT Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Merck & Co.MRK

3.7%-18.0pp

Madrigal Pharmaceuticals, Inc.MDGL

-51.7%-2.9pp

VAN

Vivani MedicalVANI

-151.1%+81.7pp

Viking TherapeuticsVKTX

-59.2%-292pp

Delcath SystemsDCTH

-0.6%—

FAQ

What is Altimmune's return on invested capital?

Altimmune (ALT) reported return on invested capital of -61.7% in Q1 2026.

How has Altimmune's return on invested capital changed year-over-year?

Altimmune's return on invested capital increased by 41.1% year-over-year, from -104.6% to -61.7%.

What is the long-term trend for Altimmune's return on invested capital?

Over 5 years (2020 to 2025), Altimmune's return on invested capital has grown at a -2.8% compound annual growth rate (CAGR), from -71.3% to -62%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.